Fig. 2From: Chemo-informatics activity prediction, ligand based drug design, Molecular docking and pharmacokinetics studies of some series of 4, 6-diaryl-2-pyrimidinamine derivatives as anti-cancer agentsPlot of residuals versus actual pIC50 values for modelling and validation setsBack to article page